Evidence map›Paper›PMID 29558974›Full record

ArticleParasites & vectors2018

Wolbachia diversity and cytoplasmic incompatibility patterns in Culex pipiens populations in Turkey.

Mine Altinli, Filiz Gunay, Bulent Alten, Mylene Weill, Mathieu Sicard

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. EuropeanInsects · 2024
    Article
  6. Viruses · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Modeling emergence ofFrontiers in microbiology · 2023
    Article
  12. Article
  13. NativeFrontiers in microbiology · 2023
    Article
  14. Article
  15. Symbiotic Interactions Between Mosquitoes and Mosquito Viruses.Frontiers in cellular and infection microbiology · 2021
    Review
  16. Article
  17. Article
  18. Evolution and phylogeography ofVirus evolution · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mine AltinliInstitut des Sciences de l'Evolution de Montpellier (CNRS-Université de Montpellier-IRD-EPHE), Montpellier, France. mine.altinli@umontpellier.fr.ORCID 0000-0001-8557-9442
Filiz GunayFaculty of Sciences, Department of Biology, Division of Ecology, VERG Laboratories, Hacettepe University, Ankara, Turkey.
Bulent AltenFaculty of Sciences, Department of Biology, Division of Ecology, VERG Laboratories, Hacettepe University, Ankara, Turkey.
Mylene WeillInstitut des Sciences de l'Evolution de Montpellier (CNRS-Université de Montpellier-IRD-EPHE), Montpellier, France.
Mathieu SicardInstitut des Sciences de l'Evolution de Montpellier (CNRS-Université de Montpellier-IRD-EPHE), Montpellier, France. mathieu.sicard@umontpellier.fr.
Centre National de la Recherche Scientifique · FRHacettepe University · TR

Funding

Agence Nationale de la Recherche ANR-16-CE02-0006-01
6 · The paper itself

Abstract

backgroundWolbachia are maternally transmitted bacteria that can manipulate their hosts' reproduction causing cytoplasmic incompatibility (CI). CI is a sperm-egg incompatibility resulting in embryonic death. Due to this sterilising effect on mosquitoes, Wolbachia are considered for vector control strategies. Important vectors for arboviruses, filarial nematodes and avian malaria, mosquitoes of Culex pipiens complex are suitable for Wolbachia-based vector control. They are infected with Wolbachia wPip strains belonging to five genetically distinct groups (wPip-I to V) within the Wolbachia B supergroup. CI properties of wPip strongly correlate with this genetic diversity: mosquitoes infected with wPip strains from a different wPip group are more likely to be incompatible with each other. Turkey is a critical spot for vector-borne diseases due to its unique geographical position as a natural bridge between Asia, Europe and Africa. However, general wPip diversity, distribution and CI patterns in natural Cx. pipiens (s.l.) populations in the region are unknown. In this study, we first identified wPip diversity in Turkish Cx. pipiens (s.l.) populations, by assigning them to one of the five groups within wPip (wPip-Ito V). We further investigated CI properties between different wPip strains from this region.

resultsWe showed a wPip fixation in Cx. pipiens (s.l.) populations in Turkey by analysing 753 samples from 59 sampling sites. Three wPip groups were detected in the region: wPip-I, wPip-II and wPip-IV. The most dominant group was wPip-II. While wPip-IV was restricted to only two locations, wPip-I and wPip-II had wider distributions. Individuals infected with wPip-II were found co-existing with individuals infected with wPip-I or wPip-IV in some sampling sites. Two mosquito isofemale lines harbouring either a wPip-I or a wPip-II strain were established from a population in northwestern Turkey. Reciprocal crosses between these lines showed that they were fully compatible with each other but bidirectionally incompatible with wPip-IV Istanbul infected line.

conclusionOur findings reveal a high diversity of wPip and CI properties in Cx. pipiens (s.l.) populations in Turkey. Knowledge on naturally occurring CI patterns caused by wPip diversity in Turkey might be useful for Cx. pipiens (s.l.) control in the region.

Indexed as

Disease VectorsGenetic VariationAnimalsCulexCytoplasmDNA, MitochondrialGram-Negative Bacterial InfectionsMosquito VectorsPolymerase Chain ReactionReproductionSymbiosisTurkeyWolbachiaDNA, MitochondrialCulex pipiensCytoplasmic incompatibilityTurkeyVector controlWolbachia

Identifiers

PMID29558974
PMCPMC5859491
OpenAlexW2798056689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.